Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Revenue (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Revenue readings, the most recent being $39.6 million for Q4 2025.

  • On a quarterly basis, Revenue fell 10.93% to $39.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $173.6 million, a 15.48% decrease, with the full-year FY2025 number at $173.6 million, down 15.48% from a year prior.
  • Revenue hit $39.6 million in Q4 2025 for SBC Medical Group Holdings, down from $43.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $62.3 million in Q4 2023 to a low of $39.6 million in Q4 2025.
  • Median Revenue over the past 3 years was $47.3 million (2023), compared with a mean of $48.9 million.
  • The widest YoY moves for Revenue: up 12.28% in 2024, down 28.76% in 2024.
  • SBC Medical Group Holdings' Revenue stood at $62.3 million in 2023, then decreased by 28.76% to $44.4 million in 2024, then dropped by 10.93% to $39.6 million in 2025.
  • The last three reported values for Revenue were $39.6 million (Q4 2025), $43.4 million (Q3 2025), and $43.4 million (Q2 2025) per Business Quant data.